Canada to US · Cross-listing · QNTM
Quantum Biopharma Ltd.
Quantum Biopharma Ltd. (QNTM), a Ontario-based company, cross-listed on Nasdaq on Dec 6, 2019, registering its securities on Form 40FR12B.
Quantum Biopharma, registered here under an earlier name, is an Ontario company whose forward-looking statements refer to a strategy of becoming a leading provider of products for the medical cannabis market and to clinical research on the effects of its products.
- Type
- Cross-listing
- US exchange
- Nasdaq
- Ticker
- QNTM
- Listed
- Dec 6, 2019
- Province
- Ontario
- Registration form
- 40FR12B
- Security
- Class B Subordinate Voting Shares
- Sector
- Biotech & pharma
More on this listing for subscribers
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration (40FR12B) Dec 6, 2019
- All filings on EDGAR CIK 1771885
Other Canadian companies listing in the US
- TFI International Inc.NYSE · Feb 10, 2020
- Newgioco Group, Inc.Nasdaq · Dec 23, 2019
- Metalla Royalty & Streaming Ltd.NYSE American · Dec 19, 2019
- Liminal BioSciences Inc.Nasdaq · Nov 12, 2019
- Dirtt Environmental Solutions LtdNasdaq · Sep 20, 2019
- Equinox Gold Corp.NYSE American · Sep 10, 2019